- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04211493
Empowering Health: Acute Psychological Effects of an Electromyostimulation-Whole-Body-Workout
Empowering Health: Acute Psychological Effects of a Single Electromyostimulation-Whole-Body-Workout in Participants With Depression
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Berlin, Germany, 10117
- Charité-Universitätsmedizin Berlin - Department of Psychiatry and Psychotherapy
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Subject familiarized with experimental procedure and had given written informed consent
- Depression, according to ICD-10
- BDI-II Score ≥ 14
- Able to understand German
- Reachability of participant for the two training sessions
Exclusion Criteria:
- Contraindications for physical exercise
- Contraindications for EMS-use
- Current EMS-use
- Pregnancy
- Borderline personality disorder
- Bipolar Disorder
- Schizophrenia
- Anorexia Nervosa, Bulimia Nervosa
- Dementia
- Acute suicidality
- Substance dependencies with actual consumption (except nicotine)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Experimental-Condition
20 minutes whole-body-workout with simultaneous muscle stimulation (EMS). Participants carry out easy whole-body-exercises while wearing a EMS-vest-belt-system with interwoven electrodes. During the workout the muscles are simultaneously stimulated by those external electrodes with medium level (5) of stimulation intensity. |
20 minutes whole-body-workout
Electromyostimulation-intensity 5 (muscle stimulation)
|
Placebo Comparator: Placebo-Condition
20 minutes whole-body-workout without simultaneous muscle stimulation (EMS). Participants carry out easy whole-body-exercises while wearing a EMS-vest-belt-system with interwoven electrodes. During the workout they are stimulated with the lowest possible stimulation intensity (1). This is perceptible as a slight tingling sensation but the impulse intensity lies below the muscular threshold and therefore generates no muscular activity. |
20 minutes whole-body-workout
Electromyostimulation-intensity 1 (no muscle stimulation)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in depressive symptoms
Time Frame: From directly before the intervention to immediately after the intervention - both: before/after the EMS-training-session and before/after the Placebo-session
|
Depressive symptoms are measured using the State-Scale of the State-Trait Depression Scales (STDS) by Spaderna, Schmukle & Krohne (2002).
The SDTS State-Scale has two subscales with each 5 likert scaled items with values ranging from 1 to 4. Higher scores mean a worse outcome for the first subscale and a better outcome for the second subscale.
|
From directly before the intervention to immediately after the intervention - both: before/after the EMS-training-session and before/after the Placebo-session
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in anxiety symptoms
Time Frame: From directly before the intervention to immediately after the intervention - both: before/after the EMS-training-session and before/after the Placebo-session
|
Anxiety symptoms are measured using the the State-Scale of the State-Trait Anxiety Inventory (STAI) by Laux, Glanzmann, Schaffner & Spielberger (1981).
The STAI State-Scale has 20 likert scaled items with values ranging from 1 to 4, higher scores mean a worse outcome.
|
From directly before the intervention to immediately after the intervention - both: before/after the EMS-training-session and before/after the Placebo-session
|
Change in general self-efficacy
Time Frame: From directly before the intervention to immediately after the intervention - both: before/after the EMS-training-session and before/after the Placebo-session
|
General self-efficacy is measured using the General-Self-Efficacy Scale (GSE) by Jerusalem & Schwarzer (1981).
The GSE has 10 likert scaled items with values ranging from 1 to 4, higher scores mean a better outcome.
|
From directly before the intervention to immediately after the intervention - both: before/after the EMS-training-session and before/after the Placebo-session
|
Change in intention for physical activity
Time Frame: From directly before the intervention to immediately after the intervention - both: before/after the EMS-training-session and before/after the Placebo-session
|
Intention for physical activity is measured using two likert scaled items by Petzold et al. (2017).
Values ranging from 1 to 4, higher scores mean a better outcome.
|
From directly before the intervention to immediately after the intervention - both: before/after the EMS-training-session and before/after the Placebo-session
|
Change in self-efficacy regarding physical activity
Time Frame: From directly before the intervention to immediately after the intervention - both: before/after the EMS-training-session and before/after the Placebo-session
|
Self-efficacy is measured using two likert scaled items by Petzold et al. (2017).
Values ranging from 1 to 4, higher scores mean a better outcome.
|
From directly before the intervention to immediately after the intervention - both: before/after the EMS-training-session and before/after the Placebo-session
|
Collaborators and Investigators
Investigators
- Study Director: Andreas Ströhle, Prof.Dr., Charité-Universitätsmedizin Berlin - Department of Psychiatry and Psychotherapy
- Principal Investigator: Antonia Bendau, M.Sc.Psych., Charité-Universitätsmedizin Berlin - Department of Psychiatry and Psychotherapy
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- EA4/058/19
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States
Clinical Trials on whole-body-workout
-
Charite University, Berlin, Germanymiha bodytec GmbHUnknown
-
Gazi UniversityGulhane Training and Research HospitalRecruitingArthropathy of Knee | Whole-body Vibration | Swelling/ EdemaTurkey
-
Federal University of Health Science of Porto AlegreCompletedChronic Obstructive Pulmonary DiseaseBrazil
-
The Hong Kong Polytechnic UniversityUnknown
-
Federal University of Health Science of Porto AlegreLeonhardt Ventures LLCNot yet recruiting
-
The Hong Kong Polytechnic UniversityCompleted
-
Federal University of Health Science of Porto AlegreNot yet recruiting
-
University of ZurichNot yet recruitingMajor Depressive Disorder
-
Daping Hospital and the Research Institute of Surgery...Children's Hospital of Chongqing Medical University; Children's Hospital of... and other collaboratorsWithdrawnBrain Injury | Hypoxic- Ischemic Encephalopathy | Whole-Body HypothermiaChina